Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/20/1998WO1998035984A2 Compositions and methods for highly efficient transfection
08/20/1998WO1998035983A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998WO1998035982A1 Compounds for use in adept
08/20/1998WO1998035981A1 Prevention and treatment of hepatocellular cancer
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035705A1 Use of heat shock proteins to deliver moieties into cells
08/20/1998WO1998035698A1 Remedies for lymphocytic tumors
08/20/1998WO1998035697A1 Improved method for the reduction of neointima formation after angioplasty
08/20/1998WO1998035696A1 Use of thymosin alpha 1 for the manufacture of a medicament for promoting stem cell development
08/20/1998WO1998035695A1 Wound healing
08/20/1998WO1998035694A2 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
08/20/1998WO1998035693A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
08/20/1998WO1998035692A1 Materials and methods relating to the protection of useful immune cells
08/20/1998WO1998035691A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998WO1998035690A1 Peptide modulation of reperfusion injury
08/20/1998WO1998035689A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998WO1998035688A1 Method for destroying retinal pigment epithelial cells
08/20/1998WO1998035684A2 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
08/20/1998WO1998035683A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
08/20/1998WO1998035669A1 Methods for administering nutritional indium
08/20/1998WO1998035666A1 Formulations of nanoparticle naproxen tablets
08/20/1998WO1998035661A1 Preparation of a pulmonary surfactant for instillation and oral application
08/20/1998WO1998035659A1 Bak promotor expression system
08/20/1998WO1998035653A1 Implantable collagen-containing putty material
08/20/1998WO1998035554A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998WO1998024911A3 Mutants of streptococcal toxin a and methods of use
08/20/1998WO1998022136A3 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
08/20/1998WO1998018931A3 Streptococcus pneumoniae polynucleotides and sequences
08/20/1998WO1998017689A3 Il-12 gene expression and delivery systems and uses
08/20/1998WO1998017284A3 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998WO1998013492A3 Isolation and use of motoneuronotrophic factors
08/20/1998CA2284093A1 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
08/20/1998CA2282683A1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998CA2282426A1 Use of heat shock proteins to deliver moieties into cells
08/20/1998CA2281690A1 Method for destroying retinal pigment epithelial cells
08/20/1998CA2281224A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2281033A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998CA2281032A1 Modified cytokine receptor protein
08/20/1998CA2281000A1 Diagnosis and treatment of glaucoma
08/20/1998CA2280998A1 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
08/20/1998CA2280968A1 Secreted proteins and polynucleotides encoding them
08/20/1998CA2280896A1 Novel human mago nashi protein
08/20/1998CA2280700A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998CA2280634A1 Human p24 vesicle proteins
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2279838A1 Receptor that binds trail
08/20/1998CA2279492A1 Immunological tolerance to hiv epitopes
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/19/1998EP0859056A2 Human nerve growth factor
08/19/1998EP0859055A1 Cloning of a novel g-protein coupled 7tm receptor
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859052A1 Cloning of human GPR14 receptor
08/19/1998EP0859009A2 Recombinant human hepatocyte growth factor and method for production thereof
08/19/1998EP0859007A1 Cyclic hexapeptide compounds
08/19/1998EP0859005A1 Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same
08/19/1998EP0858809A1 Method of preventing tpo adsorption and stable tpo-containing composition
08/19/1998EP0858808A2 Peptides for use in wound treatment
08/19/1998EP0858742A2 Nitrate-free powdered fruits or vegetables and manufacturing process therefor
08/19/1998EP0858508A1 Novel peptides useful in enhancement of fsh action
08/19/1998EP0858506A2 Genetic induction of receptors for targeted radiotherapy
08/19/1998EP0858505A1 Cloning of vertebrate pheromone receptors and uses thereof
08/19/1998EP0858504A1 Diagnostics and treatments of periodontal disease
08/19/1998EP0858503A1 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS
08/19/1998EP0858467A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
08/19/1998EP0858466A1 Use of protein gax for treating cancer
08/19/1998EP0858465A2 Anti-tumoral protein
08/19/1998EP0858464A1 Thrombin inhibitors
08/19/1998EP0858456A1 Triterpene derivatives with immunosuppressant activity
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0858345A1 Use of muteins of wild-type cytokines as immunogens
08/19/1998EP0858344A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
08/19/1998EP0858343A1 Continuous low-dose cytokine infusion therapy
08/19/1998EP0858340A1 Combination therapy for the treatment of diabetes and obesity
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858323A1 Process to manufacture implants containing bioactive peptides
08/19/1998EP0858262A1 Thrombin inhibitors
08/19/1998EP0812210A4 Compositions and methods for enhancing the growth of hair and restoring hair color
08/19/1998EP0765166A4 Radiolabeled annexin-galactose conjugates
08/19/1998EP0733057A4 Origin of replication complex genes, proteins and methods
08/19/1998EP0703926B1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
08/19/1998EP0684997B1 Anthrax toxin fusion proteins and uses thereof
08/19/1998EP0637247B1 Treatment of herpesvirus infection
08/19/1998EP0618809B1 Bradykinin type peptides
08/19/1998EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
08/19/1998EP0422215B1 Antibacterial and antimalarial peptides
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190897A Stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calctum ions
08/19/1998CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue
08/19/1998CN1190895A Use of ribavirin and interferon alpha for the treatment of hepatitis C
08/19/1998CN1190894A Method for identifying or isolating a molecule and molecules indentified thereby
08/19/1998CN1190893A Compound and compositions for delivering active agents
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795974 Genetic engineering
08/18/1998US5795968 Polypeptide derivatives of human granulocyte colony stimulating factor
08/18/1998US5795967 Tumor necrosis factor antagonists and their use
08/18/1998US5795966 Antagonists of interleukin-15
08/18/1998US5795965 Reshaped human to human interleukin-6 receptor
1 ... 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 ... 3163